DNA polymerase IIIC inhibitors and use thereof
US10723741B1 · kind B1 · utility
0Cited by
5References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 19, 2019 |
| Grant date | Jul 28, 2020 |
| Priority date | — |
| Expiry date | Dec 19, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds and methods useful for inhibiting the DNA polymerase IIIC enzyme. The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using said compositions in the treatment of Gram-positive bacteria infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.